2-(4-(二苯并[b,f][1,4]硫氮杂卓-11-基)哌嗪-1-基)乙醇结构式
|
常用名 | 2-(4-(二苯并[b,f][1,4]硫氮杂卓-11-基)哌嗪-1-基)乙醇 | 英文名 | 4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol |
|---|---|---|---|---|
| CAS号 | 329216-67-3 | 分子量 | 339.454 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 523.4±60.0 °C at 760 mmHg | |
| 分子式 | C19H21N3OS | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 270.3±32.9 °C |
| 中文名 | 4-二苯并[b,f][1,4]硫氮杂卓-11-基-1-哌嗪乙醇 |
|---|---|
| 英文名 | 2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethanol |
| 中文别名 | 富马酸喹硫平杂质 I |
| 英文别名 | 更多 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 523.4±60.0 °C at 760 mmHg |
| 分子式 | C19H21N3OS |
| 分子量 | 339.454 |
| 闪点 | 270.3±32.9 °C |
| 精确质量 | 339.140533 |
| PSA | 64.37000 |
| LogP | 2.27 |
| 蒸汽压 | 0.0±1.4 mmHg at 25°C |
| 折射率 | 1.683 |
| 储存条件 | 2-8°C |
|
~51%
2-(4-(二苯并[b,f][... 329216-67-3 |
| 文献:CONCERT PHARMACEUTICALS INC. Patent: WO2008/66620 A2, 2008 ; Location in patent: Page/Page column 23-24 ; |
|
~83%
2-(4-(二苯并[b,f][... 329216-67-3 |
| 文献:AUSPEX PHARMACEUTICALS, INC. Patent: US2010/69356 A1, 2010 ; Location in patent: Page/Page column 26-27 ; US 20100069356 A1 |
|
~92%
2-(4-(二苯并[b,f][... 329216-67-3
详细
|
| 文献:UNION QUIMICO-FARMACEUTICA S.A. Patent: WO2006/94549 A1, 2006 ; Location in patent: Page/Page column 17-18 ; |
|
~%
2-(4-(二苯并[b,f][... 329216-67-3 |
| 文献:Warawa; Migler; Ohnmacht; Needles; Gatos; McLaren; Nelson; Kirkland Journal of Medicinal Chemistry, 2001 , vol. 44, # 3 p. 372 - 389 |
| 1-Piperazineethanol, 4-dibenzo[b,f][1,4]thiazepin-11-yl- |
| Quetiapine Hydroxy Impurity Dihydrochloride Salt |
| 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol |
| 4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol |
| T C676 BS INJ C- AT6N DNTJ D2Q |
| O-Dealkyl Quetiapine |
| 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethanol |
| Quetiapine Hydroxy Impurity |
| 4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazineethanol |
| Quetiapine Impurity 2 |